Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke

Abroad (travel likely)Recruiting

Conditions

Patent Foramen Ovale · Ischemic Stroke · Bleeding Ulcer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

IUCPQ, Québec, Quebec, Canada
Contact: Study coordinator (Josep Rodes-Cabau, MD) · josep.rodes@criucpq.ulaval.ca · 4186568711
Contact: Study coordinator (Melanie Cote, MSc) · josep.rodes@criucpq.ulaval.ca · 4186568711
Contact: Principal Investigator (Josep Rodes-Cabau, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

Stroke · PFO - Patent Foramen Ovale

Abroad (travel likely)Recruiting

Tucson, United States · La Jolla, United States

Pulmonary Embolism and Right-to-Left Shunts

Pulmonary Embolism (PE) · Right-to-Left Shunt · Stroke

Abroad (travel likely)Recruiting

Boston, United States

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

Cryptogenic Ischemic Stroke · Patent Foramen Ovale

Abroad (travel likely)RecruitingPHASE3

Amiens, France · Bayonne, France

SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation

Ischemic Stroke · Embolic Stroke of Undetermined Source · Patent Foramen Ovale (PFO)

Abroad (travel likely)Recruiting

Taichung, Taiwan · Taipei, Taiwan